Back to Research

Organization profile

Microsynth

Microsynth is a leading European biotechnology company specializing in nucleic acid synthesis and genomic analysis, supporting the development of advanced therapies and molecular diagnostics. Founded as a spin-off from ETH Zurich, the organization provides a wide spectrum of services including DNA/RNA sequencing, oligonucleotide synthesis, and GxP-compliant contract research.

Balgach, SwitzerlandFounded 1989

Overview

1. Executive Summary (Confidence: High)

Since its founding in 1989 by Dr. Tobias Schmidheini, Microsynth AG has grown from a specialized "garage startup" into an essential pillar of the European life sciences infrastructure.[1] Headquartered in Balgach, Switzerland, the company operates across three primary business areas: DNA/RNA synthesis, DNA/RNA analysis (including Sanger and Next-Generation Sequencing), and contract research/outsourcing.[1] With a workforce of over 130 and subsidiaries in Germany, Austria, and France, Microsynth supports the longevity ecosystem by providing high-quality genomic tools required for the development of cell, gene, and mRNA therapies.[3] The organization is distinguished by its deep technical expertise and its commitment to quality, holding numerous ISO and Swissmedic GMP certifications that enable it to serve the most regulated sectors of the pharmaceutical industry.[3]

This is an extract of the full organization profile. To access the full company profile, .

Desktop only

Research is currently available on desktop only.

The Research module is designed for larger screens. Please reopen it on a desktop or laptop to use the screener, filters, detail pages, and admin tools.

Microsynth | Longevity Organization Profile | Masters of Longevity